High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation
Methods in Enzymology · 2023
DOI: 10.1016/bs.mie.2023.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2023. Verfasst von Drake A Russell und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, University of Washington, Seattle, WA, United States. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Cytochrome P-450 Enzyme Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, University of Washington, Seattle, WA, United States.
- Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, CT, United States. Electronic address: matthew.cerny@pfizer.com.
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Russell, D. A., & Cerny, M. A. (2023). High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2023.08.002
Vancouver
Russell DA, Cerny MA. High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation. Methods in Enzymology. 2023. doi:10.1016/bs.mie.2023.08.002
BibTeX
@article{Russell2023,
author = {Russell, Drake A and Cerny, Matthew A},
title = {High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation},
journal = {Methods in Enzymology},
year = {2023},
doi = {10.1016/bs.mie.2023.08.002}
}
EUVIMED